Gene Wallenstein - Publications

Affiliations: 
Pfizer R & D, Parsippany-Troy Hills, NJ, United States 
Area:
Neuroscience & Immunology

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Molife LR, Rudman SM, Alam S, Tan DS, Kristeleit H, Middleton G, Propper D, Bent L, Stopfer P, Uttenreuther-Fischer M, Wallenstein G, de Bono J, Spicer J. Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors. Cancer Chemotherapy and Pharmacology. 72: 1213-22. PMID 24085260 DOI: 10.1007/s00280-013-2286-7  0.6
2013 Eisen T, Shparyk Y, Macleod N, Jones R, Wallenstein G, Temple G, Khder Y, Dallinger C, Studeny M, Loembe AB, Bondarenko I. Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study. Investigational New Drugs. 31: 1283-93. PMID 23625328 DOI: 10.1007/s10637-013-9962-7  0.6
2008 Feifel U, Wallenstein G, Rominger KL, Trommeshauser D, Platz J. Pharmacokinetics and tolerability (Study 1) with particular reference to ocular safety (Study 2) of tiotropium Respimat soft mist inhaler: findings from two dose-ranging studies in healthy men. International Journal of Chronic Obstructive Pulmonary Disease. 3: 397-403. PMID 18990967  0.6
2007 Brand P, Meyer T, Weuthen T, Timmer W, Berkel E, Wallenstein G, Scheuch G. Lung deposition of radiolabeled tiotropium in healthy subjects and patients with chronic obstructive pulmonary disease. Journal of Clinical Pharmacology. 47: 1335-41. PMID 17625157 DOI: 10.1177/0091270006295788  0.6
2004 Iovino M, Feifel U, Yong CL, Wolters JM, Wallenstein G. Safety, tolerability and pharmacokinetics of BIBN 4096 BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers. Cephalalgia : An International Journal of Headache. 24: 645-56. PMID 15265053 DOI: 10.1111/j.1468-2982.2004.00726.x  0.6
2004 Van Ryn J, Kink-Eiband M, Kuritsch I, Feifel U, Hanft G, Wallenstein G, Trummlitz G, Pairet M. Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers. Journal of Clinical Pharmacology. 44: 777-84. PMID 15199082 DOI: 10.1177/0091270004266623  0.6
2002 Wallenstein GV, Vago DR, Walberer AM. Time-dependent involvement of PKA/PKC in contextual memory consolidation. Behavioural Brain Research. 133: 159-64. PMID 12110449 DOI: 10.1016/S0166-4328(01)00476-4  1
2001 Wallenstein GV, Vago DR. Intrahippocampal scopolamine impairs both acquisition and consolidation of contextual fear conditioning. Neurobiology of Learning and Memory. 75: 245-52. PMID 11300731 DOI: 10.1006/nlme.2001.4005  1
2000 Kesner RP, Gilbert PE, Wallenstein GV. Testing neural network models of memory with behavioral experiments. Current Opinion in Neurobiology. 10: 260-5. PMID 10753789 DOI: 10.1016/S0959-4388(00)00067-2  1
1999 Kwon JS, O'Donnell BF, Wallenstein GV, Greene RW, Hirayasu Y, Nestor PG, Hasselmo ME, Potts GF, Shenton ME, McCarley RW. Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Archives of General Psychiatry. 56: 1001-5. PMID 10565499 DOI: 10.1001/archpsyc.56.11.1001  1
1999 Wallenstein GC, Stangier J, Ludden TM. Analyzing rich data using different methods provided by NONMEM: pharmacokinetics of telmisartan following intravenous infusion to healthy volunteers. Pharmaceutical Research. 16: 772-6. PMID 10350024 DOI: 10.1023/A:1011997229669  0.6
1999 Fransén E, Wallenstein GV, Alonso AA, Dickson CT, Hasselmo ME. A biophysical simulation of intrinsic and network properties of entorhinal cortex Neurocomputing. 26: 375-380. DOI: 10.1016/S0925-2312(99)00027-2  1
1998 Wallenstein GV, Eichenbaum H, Hasselmo ME. The hippocampus as an associator of discontiguous events. Trends in Neurosciences. 21: 317-23. PMID 9720595 DOI: 10.1016/S0166-2236(97)01220-4  1
1997 Wallenstein GV, Hasselmo ME. Functional transitions between epileptiform-like activity and associative memory in hippocampal region CA3. Brain Research Bulletin. 43: 485-93. PMID 9250622 DOI: 10.1016/S0361-9230(97)00003-8  1
1997 Wallenstein GV, Hasselmo ME. GABAergic modulation of hippocampal population activity: sequence learning, place field development, and the phase precession effect. Journal of Neurophysiology. 78: 393-408. PMID 9242288  1
1996 Hasselmo ME, Wyble BP, Wallenstein GV. Encoding and retrieval of episodic memories: role of cholinergic and GABAergic modulation in the hippocampus. Hippocampus. 6: 693-708. PMID 9034856 DOI: 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W  1
1996 Wallenstein GV. Adenosinic modulation of 7-14 Hz spindle rhythms in interconnected thalamic relay and nucleus reticularis neurons. Neuroscience. 73: 93-8. PMID 8783233 DOI: 10.1016/0306-4522(95)00499-8  1
1995 Wallenstein GV, Nash AJ, Kelso JA. Frequency and phase characteristics of slow cortical potentials preceding bimanual coordination. Electroencephalography and Clinical Neurophysiology. 94: 50-9. PMID 7530639 DOI: 10.1016/0013-4694(94)00220-F  1
1995 Wallenstein GV, Kelso JAS, Bressler SL. Phase transitions in spatiotemporal patterns of brain activity and behavior Physica D: Nonlinear Phenomena. 84: 626-634. DOI: 10.1016/0167-2789(95)00056-A  1
1994 Wallenstein GV. A model of the electrophysiological properties of nucleus reticularis thalami neurons. Biophysical Journal. 66: 978-88. PMID 8038402 DOI: 10.1016/S0006-3495(94)80879-3  1
1994 Wallenstein GV. The role of thalamic IGABAB in generating spike-wave discharges during petit mal seizures. Neuroreport. 5: 1409-12. PMID 7919211  1
1994 Wallenstein GV. Simulation of GABAB-receptor-mediated K+ current in thalamocortical relay neurons: tonic firing, bursting, and oscillations. Biological Cybernetics. 71: 271-80. PMID 7918804 DOI: 10.1007/BF00202766  1
1993 Wallenstein G, Gladigau V. Dose linearity of clonidine after transdermal application. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society. 3: 369-72. PMID 8193523 DOI: 10.1007/BF01829455  0.6
1993 Wallenstein GV. Spatial mode dynamics of a thalamo-cortical network Proceedings of Spie - the International Society For Optical Engineering. 2036: 301-312.  1
Show low-probability matches.